Pharmalot… Pharmalittle… Morning Edition
Make a commentBy Ed Silverman // November 17th, 2009 // 7:05 am
Good morning, everyone. Nice to see you again. Another pleasant day looks to be shaping up on the Pharmalot corporate campus. But so much to do and we know you can relate. So while we shuttle to and from the schoolhouse, here are a few items to help you on your own way….
Roche Applies for Avastin Breast Cancer Use (Reuters)
FDA Delays Genzyme Pompe Disease Drug Again (MassHighTech)
Icahn Buys Shares in Genzyme And Forest Labs (Wall Street Journal)
Novartis Teams With Malaysia For Compound Research (Bernama)
Iowa Gets $4.3M From Medicaid Settlement (WCFCourier)
Heartburn Pills Linked To Higher Death Rate In Artery Cleanings (Bloomberg)
Talecris To Add 259 Jobs (Triangle Business Journal)
Coffee courtesy of Flickr Creative Commons chichcacha
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Avastin, Breast Cancer, Genentech, Genzyme, Malaysia, Novartis, Pompe Disease, Roche